Figure 4 — Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Research Paper|Volume 16, Issue 10|pp. 8772–8809

Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses

Back to articleFigure 4(4 of 14)

100%

Figure 4.Evaluation of MPPS model. (A) The 1-, 3-, 5-year receiver operating characteristic (ROC) curves of MPPS model in TCGA-LUAD cohort and GEO validation cohorts. (B) The 1-, 3-, 5-year area under curves (AUC) of MPPS model and 51 published prognostic models of LUAD. (C) C-index of MPPS model and 51 published prognostic models of LUAD.